Providence Medical Technology enrolled its first patients for a randomized controlled trial for its Corus-LX system for degenerative lumbosacral disease, according to a March 19 news release.
The multicenter trial will focus on patients who qualify for two-level interbody fusion with supplemental percutaneous pedicle screw fixation and posterior fusion. Subjects will either have surgery with the Corus-Lx system or with a standard posterior fusion technique.
Kade Huntsman, MD, of the Huntsman Spinal Clinic in Salt Lake City, was the first clinical investigator to treat an enrolled patient with the Corus-Lx device. He used a circumferential fusion approach and integrated lumbar interbody fusion with percutaneous pedicle screws and the CORUS-LX System.
The study aims to evaluate subjects through 2027.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
